XVIPF OTC
Xvivo Perfusion AB (publ)
1W: -12.8%
1M: -29.6%
3M: -24.8%
YTD: +5.3%
1Y: +14.4%
3Y: -4.0%
5Y: -31.8%
$21.80
-1.05 (-4.60%)
Weekly Expected Move ±9.7%
$18
$20
$22
$24
$26
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$2.4B
-1.4% ▼
5Y CAGR: +15.5%
Total Liabilities
$260M
+5.7% ▲
5Y CAGR: +12.9%
Shareholders Equity
$2.1B
-2.3% ▼
5Y CAGR: +15.9%
Cash & Investments
$291M
-29.9% ▼
5Y CAGR: -3.8%
Total Debt
$237M
+597.0% ▲
5Y CAGR: +101.1%
Net Debt
-$54M
+85.8% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $399M | $247M | $546M | $416M | $291M |
| Short-Term Investments | $0 | $0 | $300K | $0 | $0 |
| Cash & ST Investments | $399M | $247M | $546M | $416M | $291M |
| Net Receivables | $60M | $100M | $98M | $132M | $147M |
| Inventory | $78M | $107M | $142M | $227M | $248M |
| Other Current Assets | $12M | $10M | $20M | $9M | $10 |
| Total Current Assets | $548M | $468M | $826M | $813M | $686M |
| Property, Plant & Equip. | $26M | $48M | $98M | $149M | $213M |
| Goodwill & Intangibles | $925M | $1.2B | $622M | $1.4B | $1.4B |
| Long-Term Investments | $1M | $411K | $582K | $898K | $22M |
| Other Non-Current Assets | $0 | $0 | $649M | $0 | $10 |
| Total Non-Current Assets | $995M | $1.3B | $1.4B | $1.6B | $1.7B |
| Total Assets | $1.5B | $1.7B | $2.2B | $2.4B | $2.4B |
| — Liabilities — | |||||
| Accounts Payable | $21M | $38M | $36M | $39M | $108M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $12M |
| Deferred Revenue | $47M | $54M | $4M | $0 | $0 |
| Other Current Liabilities | -$15M | -$16M | $16M | $115M | $0 |
| Total Current Liabilities | $105M | $135M | $134M | $178M | $119M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $113M |
| Other Non-Current Liab. | $150M | $163M | $95M | $45M | -$85M |
| Total Non-Current Liabilities | $153M | $168M | $116M | $68M | $141M |
| Total Liabilities | $257M | $303M | $251M | $246M | $260M |
| — Equity — | |||||
| Common Stock | $754K | $762K | $805K | $805K | $817K |
| Retained Earnings | $9M | $28M | $120M | $292M | $316M |
| Accumulated OCI | $22M | $88M | $0 | $0 | $11M |
| Total Stockholders Equity | $1.3B | $1.4B | $1.9B | $2.2B | $2.1B |
| Total Liabilities & Equity | $1.5B | $1.7B | $2.2B | $2.4B | $2.4B |
| — Key Metrics — | |||||
| Total Debt | $6M | $10M | $31M | $34M | $237M |
| Net Debt | -$393M | -$237M | -$514M | -$381M | -$54M |
| Total Investments | $1M | $411K | $882K | $898K | $22M |